Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Cancers|May 28, 2022
Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in CancerPrathibha Mohan, Joyce Pasion, Giovanni Ciriello, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Real-Time RT-PCR Tests on Oral Rinses and Saliva SamplesN Esther Babady, Tracy McMillen, Krupa Jani, et al.
Nature Communications|February 3, 2016
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitisKrista Dubin, Margaret K Callahan, Boyu Ren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinibJuliann Chmielecki, M Catherine Pietanza, Dana Aftab, et al.
Acta Neuropathologica|December 3, 2013
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlatesEdward R Kastenhuber, Jason T Huse, Samuel H Berman, et al.
Cancer Immunity|February 3, 2005
Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformaticsNeil H Segal, Nathalie E Blachere, Jose A Guevara-Patiño, et al.
Molecular Cell|August 21, 2007
Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assemblySrihari C Sampath, Ivan Marazzi, Kyoko L Yap, et al.
Plos One|December 6, 2011
Stat3 mediates expression of autotaxin in breast cancerJaneen Azare, Ashley Doane, Kenneth Leslie, et al.
The Journal of Clinical Investigation|November 25, 2010
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humansCarles Ubeda, Ying Taur, Robert R Jenq, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2011
Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET InhibitionThomas Bachleitner-Hofmann, Mark Y Sun, Chin-Tung Chen, et al.
Pageof 16